FLI1 Expression in Invasive Breast Carcinoma: Clinicopathological Correlations and Prognostic Implications
Genes · 2025
DOI: 10.3390/genes16111313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Nusrat Jahan Doly und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Dhaka Medical College, Dhaka 1000, Bangladesh. Hauptthemen laut MEDLINE: Proto-Oncogene Protein c-fli-1, Breast Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The E26 transformation-specific (ETS) transcription factor Friend Leukemia Integration 1 (FLI1) has been linked to breast cancer aggressiveness, stromal remodeling, and immune modulation, yet the regulatory mechanisms governing its activity remain poorly defined. Of note, various studies have shown that EWS-FLI1-mediated transcription programs are facilitated via direct recruitment and binding of the NuRD-LSD1 complex, regulating its associated gene targets. Furthermore, LSD1 inhibition exhibited reverse transcriptional profiles driven by ETS-FLI and reduced in vivo tumorigenesis in cancers.
Methods
We evaluated FLI1 expression across multiple invasive breast carcinoma (IBC) cohorts to determine its prognostic significance and associations with stromal features. In parallel, we investigated FLI1 regulation in humanized breast cancer mouse models treated with an LSD1 inhibitor.
Results
High FLI1 expression was associated with advanced histological grade in IBC, consistent with an oncogenic function. FLI1-high tumors also exhibited elevated stromal and immune scores, indicating a role in remodeling the tumor microenvironment. Additionally, LSD1 inhibition downregulated FLI1 target genes involving angiogenesis and invasion.
Conclusions
These findings highlight the dual role of FLI1: tumor-intrinsic FLI1 promotes proliferation and invasion, whereas its transcriptional regulation in tumor and endothelial compartments likely reflects LSD1 dependence. Collectively, our results support a mechanistic model in which LSD1–FLI1 crosstalk is involved in immune and stromal remodeling, positioning FLI1 as both a marker of tumor aggressiveness and a potential predictor of response to epigenetic therapies in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Dhaka Medical College, Dhaka 1000, Bangladesh.
- Division of Pathology, Singapore General Hospital Academia, Singapore 169856, Singapore.
- Department of Pathology, National Institute of Burn and Plastic Surgery, Dhaka 1000, Bangladesh.
- Department of Pathology, Greenlife Medical College, Dhaka 1205, Bangladesh.
- Translational Research and Innovation Laboratory, Singapore General Hospital Academia, Singapore 169856, Singapore.
- Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore 138673, Singapore.
ORCID-Profile: Qingfeng Chen, Jabed Iqbal
Zitieren
APA
Doly, N. J., Lee, D. Y., Tahsin, K. N., Akhter, J., Sultana, S., Khatun, J., Chua, S. Z., Banu, A. T., Chen, Q., & Iqbal, J. (2025). FLI1 Expression in Invasive Breast Carcinoma: Clinicopathological Correlations and Prognostic Implications. Genes. https://doi.org/10.3390/genes16111313
Vancouver
Doly NJ, Lee DY, Tahsin KN, Akhter J, Sultana S, Khatun J, et al. FLI1 Expression in Invasive Breast Carcinoma: Clinicopathological Correlations and Prognostic Implications. Genes. 2025. doi:10.3390/genes16111313
BibTeX
@article{Doly2025,
author = {Doly, Nusrat Jahan and Lee, Dong Yeul and Tahsin, Kazi Nafisa and Akhter, Jhuma and Sultana, Shahana and Khatun, Julekha and Chua, Sue-Zann and Banu, A Tasleema and Chen, Qingfeng and Iqbal, Jabed},
title = {FLI1 Expression in Invasive Breast Carcinoma: Clinicopathological Correlations and Prognostic Implications},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16111313}
}
EUVIMED